ARCA biopharma Stock (NASDAQ: ABIO) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 1.396M |
Day Range | - - - |
52 Wk Range | 1.560 - 3.880 |
Market Cap | $47.709M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 81 |
Short Interest | 1.89% |
Days to Cover | 7.07 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of ARCA biopharma (NASDAQ: ABIO) through any online brokerage.
Other companies in ARCA biopharma’s space includes: Kezar Life Sciences (NASDAQ:KZR), Gain Therapeutics (NASDAQ:GANX), Intensity Therapeutics (NASDAQ:INTS), Immuneering (NASDAQ:IMRX) and Aligos Therapeutics (NASDAQ:ALGS).
The latest price target for ARCA biopharma (NASDAQ: ABIO) was reported by Dawson James on Wednesday, October 9, 2013. The analyst firm set a price target for 3.75 expecting ABIO to rise to within 12 months (a possible 13.98% upside). 0 analyst firms have reported ratings in the last year.
The stock price for ARCA biopharma (NASDAQ: ABIO) is $3.29 last updated April 22, 2024 at 8:34 AM EDT.
There are no upcoming dividends for ARCA biopharma.
ARCA biopharma’s Q2 earnings are confirmed for Friday, July 19, 2024.
There is no upcoming split for ARCA biopharma.
ARCA biopharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.